Pines Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Sell
682
-360
-35% -$134K 0.08% 194
2026
Q1
$305K Sell
1,042
-10
-1% -$3.29K 0.1% 174
2025
Q4
$369K Buy
1,052
+41
+4% +$13.9K 0.12% 158
2025
Q3
$327K Buy
1,011
+317
+46% +$98.6K 0.11% 172
2025
Q2
$241K Buy
694
+158
+29% +$63.6K 0.09% 197
2025
Q1
$231K Sell
536
-30
-5% -$12K 0.11% 180
2024
Q4
$216K Buy
+566
New +$237K 0.09% 195

Other funds holding ELV

Pines Wealth Management's ELV Position: Q2 2026 in Review

Pines Wealth Management reduced its Elevance Health (ELV) stake by 35% in Q2 2026, selling an estimated $134K and leaving 682 shares worth $264K. The position accounts for 0.08% of the portfolio, ranked #194.

Pines Wealth Management first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $369K in Q4 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Pines Wealth Management held 682 shares of Elevance Health worth $264K as of Q2 2026.
  • Pines Wealth Management sold 360 Elevance Health shares in Q2 2026, an estimated $134K.
  • Elevance Health made up 0.08% of Pines Wealth Management's portfolio in Q2 2026, its #194 holding.
  • Pines Wealth Management first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Pines Wealth Management's Elevance Health position peaked at $369K in Q4 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Pines Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.